Abstract LB-130: Combinatorial treatment with intratumoral cytokine mRNAs results in high frequency of tumor rejection and development of anti-tumor immunity across a range of preclinical cancer models

作者
Timothy R. Wagenaar,Christian Hotz,Friederike Gieseke,Hui Cao,Jan Diekmann,Mustafa Diken,Christian R. Grunwitz,Andy Hebert,Karl Hsu,Marie Jordan,Katalin Karikó,Sebastian Kreiter,Andreas N. Kuhn,Mikhail N. Levit,Natalia V. Malkova,Serena Masciari,Jack Russella Pollard,Hui Qu,Abderaouf Selmi,Julia Schlereth
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:78 (13_Supplement): LB-130 被引量:5
标识
DOI:10.1158/1538-7445.am2018-lb-130
摘要

Abstract Cancer immunotherapy localized to the tumor microenvironment holds great potential to promote innate and adaptive immune responses against tumors, while avoiding toxicities related to systemic administration of immuno-modulatory therapeutics. Current strategies for tumor-targeted, gene-based delivery of immune therapies face limitations in the clinic due to suboptimal target expression, anti-vector immunity, potential for unwanted genomic rearrangements and other off target effects. We developed a highly potent synthetic mRNA-based platform for in vivo transfection and sustained intratumoral expression of immuno-modulatory molecules that is capable of inducing immunity to tumor specific antigens while avoiding anti-vector immunity and distal tissue expression often associated with viral gene therapy or oncolytic viruses. Using iterative rounds of in vivo screening in murine syngeneic tumor models, we identified a combination of four synthetic mRNAs encoding potent cytokines that mediate high frequency of complete tumor regressions across different tumor models. Mechanistically, anti-tumor activity of cytokine mRNAs relied on the action of T cells as well as NK cells and was accompanied by robust intratumoral induction of interferon gamma, systemic expansion of antigen-specific T cells and increased granzyme B positive CD8+ T cell infiltration. Immunological memory to both dominant and subdominant antigens was formed that protected long-term survivors from re-challenge with autologous tumors. Importantly, although cytokine mRNAs were administered intratumorally, resulting in local target expression, anti-tumor activity extended beyond the injected lesion to effectively control the growth of distant tumors in both a dual tumor model and in an experimental lung metastasis model. Finally, the combination of four cytokine mRNAs with immunomodulatory antibodies further enhanced the abscopal effect leading to improved overall survival and higher incidence of complete tumor regressions across several preclinical models. In summary, the robust and versatile synthetic mRNA platform reported herein was used to identify multi-modal localized cancer immunotherapy with broad anti-tumor activity against treated and untreated lesions in a range of preclinical cancer models. Citation Format: Timothy R. Wagenaar, Christian Hotz, Friederike Gieseke, Hui Cao, Jan Diekmann, Mustafa Diken, Christian Grunwitz, Andy Hebert, Karl Hsu, Marie Jordan, Katalin Kariko, Sebastian Kreiter, Andreas N. Kuhn, Mikhail Levit, Natalia Malkova, Serena Masciari, Jack Pollard, Hui Qu, Abderaouf Selmi, Julia Schlereth, Fangxian Sun, Bodo Tillmann, Tatiana Tolstykh, Lena Wicke, Sonja Witzel, Qunyan Yu, Yu-An Zhang, Gang Zheng, Gary Nabel, Joanne Lager, Ugur Sahin, Dmitri Wiederschain. Combinatorial treatment with intratumoral cytokine mRNAs results in high frequency of tumor rejection and development of anti-tumor immunity across a range of preclinical cancer models [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr LB-130.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
白锎水完成签到 ,获得积分10
刚刚
孙文远完成签到,获得积分10
刚刚
刘先生完成签到 ,获得积分10
1秒前
luckweb完成签到,获得积分10
1秒前
韭菜完成签到,获得积分10
2秒前
105完成签到 ,获得积分0
2秒前
2秒前
疯狂乱跳的脉搏完成签到 ,获得积分10
4秒前
luckweb发布了新的文献求助10
5秒前
哎呀完成签到 ,获得积分20
6秒前
xinL完成签到,获得积分10
6秒前
易翼完成签到,获得积分10
7秒前
充电宝的应助被温暖静柏采纳,获得10
9秒前
Candice完成签到,获得积分10
9秒前
KK完成签到,获得积分10
9秒前
完犊子完成签到,获得积分10
12秒前
幸福雨完成签到 ,获得积分10
13秒前
安静的ky完成签到,获得积分10
13秒前
matafeiyan完成签到,获得积分10
14秒前
YAYING完成签到 ,获得积分10
15秒前
零距离完成签到,获得积分10
16秒前
ddzzgz完成签到 ,获得积分10
17秒前
18秒前
20秒前
迷路柠檬完成签到 ,获得积分10
20秒前
卡云上完成签到,获得积分10
23秒前
韭菜盒子完成签到,获得积分10
23秒前
372925abc完成签到,获得积分10
23秒前
Hello的应助被chic采纳,获得20
25秒前
王旭倩完成签到 ,获得积分10
26秒前
Lily完成签到,获得积分10
27秒前
凌风苇岸完成签到 ,获得积分10
30秒前
小雅木子完成签到 ,获得积分10
30秒前
关远航完成签到,获得积分10
31秒前
WQ完成签到,获得积分10
32秒前
以钛的应助被雨品采纳,获得10
33秒前
精明梦柏完成签到,获得积分10
34秒前
好运来完成签到,获得积分10
34秒前
xiao xu完成签到 ,获得积分10
36秒前
冬瓜完成签到 ,获得积分10
37秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185537
求助须知:如何正确求助?哪些是违规求助? 9574270
关于积分的说明 21834871
捐赠科研通 7783247
什么是DOI,文献DOI怎么找? 3434577
关于科研通互助平台的介绍 2558951
邀请新用户注册赠送积分活动 2481370